Koch WF - Search Results

1

Exploiting protease activation for therapy.

Bleuez C, Koch WF, Urbach C, Hollfelder F, Jermutus L. Bleuez C, et al. Among authors: koch wf. Drug Discov Today. 2022 Jun;27(6):1743-1754. doi: 10.1016/j.drudis.2022.03.011. Epub 2022 Mar 18. Drug Discov Today. 2022. PMID: 35314338 Free PMC article. Review.

2

Establishing new acceptance limits for dissolution performance verification of USPC apparatus 1 and 2 using USPC prednisone tablets reference standard.

DeStefano AJ, Hauck WW, Stippler ES, Brown WE, Li C, Huang GG, Jones BJ, O'Hool K, Koch WF, Williams RL. DeStefano AJ, et al. Among authors: koch wf. Pharm Res. 2011 Mar;28(3):505-16. doi: 10.1007/s11095-010-0295-3. Epub 2010 Oct 16. Pharm Res. 2011. PMID: 20953675

3

Measurement science for food and drug monographs: toward a global system.

Koch WF, Hauck WW, de Mars SS, Williams RL. Koch WF, et al. Pharm Res. 2010 Jul;27(7):1203-7. doi: 10.1007/s11095-010-0118-6. Epub 2010 Apr 6. Pharm Res. 2010. PMID: 20372993

4

Change in criteria for USP dissolution performance verification tests.

Hauck WW, DeStefano AJ, Brown WE, Stippler ES, Abernethy DR, Koch WF, Williams RL. Hauck WW, et al. Among authors: koch wf. AAPS PharmSciTech. 2009;10(1):21-6. doi: 10.1208/s12249-008-9169-y. Epub 2009 Jan 9. AAPS PharmSciTech. 2009. PMID: 19132536 Free PMC article.

5

Early development of the human pelvic diaphragm.

Koch WF, Marani E. Koch WF, et al. Adv Anat Embryol Cell Biol. 2007;192:1-111. Adv Anat Embryol Cell Biol. 2007. PMID: 17432113 Review. No abstract available.

6

Reliability of the International Prostate Symptom Score in the assessment of patients with lower urinary tract symptoms and/or benign prostatic hyperplasia.

el Din KE, Koch WF, de Wildt MJ, Kiemeney LA, Debruyne FM, de la Rosette JJ. el Din KE, et al. Among authors: koch wf. J Urol. 1996 Jun;155(6):1959-64. doi: 10.1097/00005392-199606000-00041. J Urol. 1996. PMID: 8618297 Free article.

7

The predictive value of microscopic haematuria in patients with lower urinary tract symptoms and benign prostatic hyperplasia.

Ezz el Din K, Koch WF, de Wildt MJ, Debruyne FM, de la Rosette JJ. Ezz el Din K, et al. Among authors: koch wf. Eur Urol. 1996;30(4):409-13. doi: 10.1159/000474207. Eur Urol. 1996. PMID: 8977059 Clinical Trial.

8

The outcome of renal ultrasound in the assessment of 556 consecutive patients with benign prostatic hyperplasia.

Koch WF, Ezz el Din K, de Wildt MJ, Debruyne FM, de la Rosette JJ. Koch WF, et al. J Urol. 1996 Jan;155(1):186-9. J Urol. 1996. PMID: 7490828 Free article.

9

A dc Method for the Absolute Determination of Conductivities of the Primary Standard KCl Solutions from 0 °C to 50 °C.

Wu YC, Koch WF, Feng D, Holland LA, Juhasz E, Arvay E, Tomek A. Wu YC, et al. Among authors: koch wf. J Res Natl Inst Stand Technol. 1994 May-Jun;99(3):241-246. doi: 10.6028/jres.099.019. J Res Natl Inst Stand Technol. 1994. PMID: 37405080 Free PMC article.

10

Frozen human serum reference material for standardization of sodium and potassium measurements in serum or plasma by ion-selective electrode analyzers.

Gunaratna PC, Koch WF, Paule RC, Cormier AD, D'Orazio P, Greenberg N, O'Connell KM, Malenfant A, Okorodudu AO, Miller R, et al. Gunaratna PC, et al. Among authors: koch wf. Clin Chem. 1992 Aug;38(8 Pt 1):1459-65. Clin Chem. 1992. PMID: 1643715

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

30 results

Search Page